ARWR three-lens brief
Evidence-based stock research on ARWR. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
50-day MA below 200-day MA (death-cross regime); price below both. · RSI at 26 — technically oversold.
- 50-day MA below 200-day MA (death-cross regime); price below both.
- RSI at 26 — technically oversold.
- Underperforming SPY by 24.2pp over 30 days.
- Currently unprofitable on a trailing basis — no P/E multiple available.
- Analyst mean target $107.71 — 118% above current (14 analysts).
ARWR closed at $49.36 (+0.73%) as of 2026-11-12. Market cap: $6.95B. Price is below the 50-day MA and below the 200-day MA. Positives: analyst mean target $107.71 — 118% above current (14 analysts).. Concerns: 50-day MA below 200-day MA (death-cross regime); price below both.; rSI at 26 — technically oversold.. Last quarter: Revenue $75.25M, net income -$194.28M, free cash flow -$48.63M. Watching for: 2026-11-12 earnings release (today).
Why three lenses on ARWR, not one.
A single reasoning model has blind spots it doesn’t know about. We examine ARWR across Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://www.clearpathinvest.app/embed/ARWR" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath ARWR brief"></iframe>